The Company manufactures and markets diagnostic and therapeutic pharmaceuticals in specialty areas such as ophthalmology, rheumatology, anesthesia and antidotes, among others.
The best Bull and Bear pitches based on recency and number of recommendations.
Akorn, is a generic pharma company that has been remade by successful healthcare turnaround investor John Kapoor (Chariman of the Board). The major catalyst for this name, will be FDA approval of AKRX’s generic version of Vancocin (first to file,… More
P/b = 10.2P/S = 12.7No earningsMargins are worse with increasing inventory.Price change over 106%
Read the most recent pitches from players about AKRXQ.
Recs
Potential buying opportunity
Recs
Target $37 - $36
Recs
Outperform
Find the members with the highest scoring picks in AKRXQ.
branwann (< 20) Score: +710.11
The Score Leader is the player with the highest score across all their picks in AKRXQ.
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
---|---|---|---|---|---|---|---|---|---|---|
fiduke | 25.65 | 9/16/2010 | 5Y | $3.96 | -97.73% | +353.94% | +451.67 | 0 Comment | ||
haimp | < 20 | 10/7/2010 | 5Y | $4.17 | -97.84% | +342.58% | +440.42 | 0 Comment | ||
vbaci | 42.88 | 4/21/2010 | 5Y | $2.22 | -95.95% | +324.03% | +419.97 | 0 Comment | ||
postlapsaria | 43.22 | 1/4/2011 | 5Y | $5.64 | -98.40% | +304.50% | +402.90 | 0 Comment | ||
studpicker | 32.79 | 2/15/2008 | NS | $6.73 | -98.66% | +298.58% | +397.24 | 0 Comment | ||
seanchile | 34.91 |
|
3Y | $7.87 | -98.86% | +296.67% | +395.53 | 0 Comment | ||
ToePic | < 20 | 2/25/2008 | NS | $6.56 | -98.63% | +294.35% | +392.98 | 0 Comment | ||
30daytrend | 30.58 | 4/2/2008 | 5Y | $4.70 | -98.09% | +287.47% | +385.56 | 0 Comment | ||
dragondragon18 | 98.76 | 1/15/2008 | 1Y | $7.59 | -98.81% | +285.41% | +384.22 | 0 Comment | ||
shoutao | 96.74 | 11/19/2007 | NS | $6.80 | -98.68% | +269.84% | +368.52 | 0 Comment |
See what the Wall Street professionals think, according to their public statements and filings.